Editorial Perspectives On Data Management & Analysis

  1. Why We Need Technology Consolidation In Clinical Trials 8/16/2024

    As more and more trial designs incorporate technologies that generate an immense amount of data, data managers struggle to continuously interconnect disparate systems and standardize data. All of this fuels the need for technology consolidation.

  2. Dear Data Analysts, AI Is Not Replacing You 4/2/2024

    Deep beneath the ongoing narrative of AI’s potential use cases in clinical trials is the same fear that persists in other industries facing a technology revolution. Will jobs be lost and replaced by machines? So, I thought I’d ask an expert — a machine.

  3. It's Hard To Predict AI's Real Value To Clinical Trials 2/1/2024

    Sunny Kumar, a partner at GSR Ventures, plans to talk about AI and ML use in clinical trials during the SCOPE Summit panel, “The Future of Clinical Trial Tech: Perspectives from Different Investors.”

  4. Can Data Help Improve Diversity In Clinical Trials? 12/7/2023

    Denise Bronner Ph.D., director of diversity, equity, and inclusion in clinical trials at Johnson & Johnson Innovative Medicine (JJIM) talks about some of the types of datasets that can be leveraged to improve diversity in clinical trials.

  5. AI's Potential To Improve Clinical Operations, Trial Matching 8/11/2023

    Microsoft's Dr. Hoifung Poon explains how AI (specifically, large language models) can be used to improve patient care and clinical workflows by making it easier to match patients to trials.

  6. How Blockchain Can Empower Patients And Improve Clinical Trials 8/4/2023

    Blockchain is far bigger than cryptocurrency. It's a data encryption technology that can not only strengthen existing clinical systems, but also (and most importantly) empower patients by giving them more control and ownership of their clinical data.

  7. AstraZeneca Hopes To Advance Oncology RWE 12/6/2022

    AstraZeneca is an emerging leader in the chronic lymphocytic leukemia space. It now hopes to develop treatments so patients can avoid chemotherapy, with the hope those therapies will prolong survival in patients while also producing a better quality of life.

  8. A New Pain Treatment Requires Accurate And Reliable Data 9/21/2022

    South Rampart Pharma aims to deliver a new, affordable treatment for pain that will avoid the issues with currently marketed products. Opioids are highly addictive; patients taking excessive amounts of acetaminophen can develop liver toxicity; and NSAID over-exposure risks kidney toxicity, gastrointestinal (GI) bleeding, and worsening of high blood pressure in patients with hypertension.

  9. Walgreens Is Ready To Re-Envision Recruitment, DCTs, And RWE 9/12/2022

    Since becoming CEO of Walgreens Boots Alliance (WBA) in March 2021, Rosalind Brewer has been focused on healthcare and what the company could do to help its patients. WBA refers to the integrated healthcare, pharmacy, and retail store that currently serves millions of customers and patients every day. This past June, the company launched its clinical trial business. 

  10. How Is The Role Of Clinical Data Manager Changing? 8/30/2022

    The results of a study are only as good as the data collected. For that reason, clinical data managers (CDMs) are often the unsung heroes of clinical trials. Those managers must ensure the collected data is accurate, while avoiding tainted data that can endanger patients, studies, and the reputations of the companies conducting the research.